Product Use Indications

• Use when PCV is at or below 15%.
• Alert for transfusion begins when PCV reaches 20%.
• The principal use of whole blood is acute blood loss.
• Whole Blood modified is an alternative to whole blood.
• Packed Red Blood Cells and Fresh Frozen Plasma stored from the same donor can be administered simultaneously for the same uses as whole blood.
• Shelf life of 28 days at 4-6°C

• Use when PCV is at or below 15%.
• Alert for transfusion begins when PCV reaches 20%.
• The principal use of pRBC transfusion is anemia without deficiencies in other blood components.
• pRBC’s are useful in patients with an increased risk of volume overload.
• pRBC’s may also be used in acute hemorrhagic anemia provided they are followed by treatment with plasma products, synthetic colloid solutions and crystalloid solutions.

Other indications for use:

• Internal and external parasites
• Hemolytic disease
• Bone marrow failure
• To increase oxygen carrying capacity

• Cryopoor plasma
• Used to treat the following: Vitamin K antagonist poisoning or deficiency; hemophilia B; particularly useful in the treatment of hypoalbuminemia especially due to nephrotic syndrome; recommended in some cases of DIC
• Source of albumin
• Shelf life of 5 years if kept frozen at –18°C or colder